Skip to content

Clinical trials

Phase 3 Premature Birth trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Premature Birth Phase: Phase 3 Clear all

136 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20013
20023
20036
20044
20058
20069
20074
20088
20091
20106
20119
20124
20135
20143
20157
201610
20175
20184
20196
20201
20215
20222
20245
20253
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed74
Terminated16
Unknown status13
Withdrawn12
Not yet recruiting8
Recruiting7
Active, not recruiting5
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
NICHD Neonatal Research Network13
The George Washington University Biostatistics Center9
Federico II University6
Assistance Publique - Hôpitaux de Paris4
GlaxoSmithKline4
Ain Shams University2
Johns Hopkins Bloomberg School of Public Health2
King's College Hospital NHS Trust2
McMaster University2
NICHD Global Network for Women's and Children's Health2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Premature Birth136
Bronchopulmonary Dysplasia15
Respiratory Distress Syndrome12
Pre-Eclampsia8
Obstetric Labor, Premature7
Stillbirth5
Cerebral Palsy4
Hyperphagia4
Leukomalacia, Periventricular4
Perinatal Death4

Trials

Showing 26 to 50 of 136. Each trial links to its page on Pharma Observatory.

36 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.